Armata Pharmaceuticals
ARMP
17 hedge funds and large institutions have $3.57M invested in Armata Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 9 closing their positions.
7% less capital inflows, than outflows
Capital inflows: $2.22M | Capital outflows: $2.37M
11% less funds holding
Funds holding: 19 → 17 (-2)
13.78% less ownership
Funds ownership: 34.5% → 20.72% (-14%)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.51M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$588K |
| 3 |
Renaissance Technologies
New York
|
+$39.7K |
| 4 |
Virtu KCG Holdings
New York
|
+$37.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$25.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.28M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$492K |
| 3 |
Perceptive Advisors
New York
|
-$315K |
| 4 |
RA Capital Management
Boston,
Massachusetts
|
-$211K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$64K |
ARMP Hedge Fund Activity: Q2 2016 in Review
17 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q2 2016, worth a combined $3.57M — down 55% from $7.91M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ARMP and 7 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.51M. The largest seller was Goldman Sachs, exiting entirely with an estimated $1.28M sold.
- 17 institutional investors held Armata Pharmaceuticals (ARMP) as of Q2 2016, down from 19 in Q1 2016.
- Funds reported $3.57M of Armata Pharmaceuticals stock for Q2 2016, down 55% quarter-over-quarter.
- 7 funds opened new Armata Pharmaceuticals positions in Q2 2016 and 9 closed out, a net change of -2 holders.
- The largest Armata Pharmaceuticals buyer in Q2 2016 was Sabby Management, an estimated $1.51M added.
- The largest Armata Pharmaceuticals seller in Q2 2016 was Goldman Sachs, an estimated $1.28M sold.
Based on aggregated 13F filings for Q2 2016.